Stay updated on MT-5111 in HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.
Latest updates to the MT-5111 in HER2+ Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive study content appears to be altered.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Locations section listing study sites by state and country, expanding geographic coverage. The revision is updated to v3.3.3.SummaryDifference2%
- Check53 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. The page content and study details remain unchanged.SummaryDifference0.0%
- Check60 days agoChange DetectedThe funding-lapse notice about information timeliness has been removed. Previously, the page included a statement that information may not be up to date due to lapses in government funding, and that NIH operations status could be found at opm.gov.SummaryDifference0.3%
- Check75 days agoChange DetectedOnly minor visual and layout adjustments are evident. There are no changes to core study information such as the title, conditions, eligibility criteria, enrollment, or outcomes.SummaryDifference0.3%
- Check103 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%
Stay in the know with updates to MT-5111 in HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.